Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6138867

CCCCCCCCCCCCCCCCCCC(CCO)(C(=O)[O-])[N+](C)(C)C.[Cl-].[Na+]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.38
CES2 O00748 4/20 0.35
CA2 P00918 1/20 0.35
CES1 P23141 3/20 0.34
PSMD14 O00487 1/20 0.34
PLA2G1B P04054 1/20 0.34
MMP2 P08253 1/20 0.34
RAD52 P43351 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
LMNA P02545 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2542389 0.97 DNM1 (0.40) DNM1CES2CES1LMNAALDH1A1
SCHEMBL20853667 0.90 CES2 (0.41) CES2CES1
SCHEMBL15065991 0.86 CES2 (0.39) CES2CES1
SCHEMBL10711653 0.86 CES2 (0.39) CES2CES1
SCHEMBL7900186 0.85 CES2 (0.38) DNM1CES2CES1
SCHEMBL1033647 0.82 BBOX1 (0.30)
SCHEMBL16146094 0.81 DNM1 (0.40) DNM1CES2LMNAALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL17004781 0.81 GPR84 (0.37) CES2CA2PSMD14PLA2G1BMMP2
SCHEMBL7718266 0.81 DNM1 (0.40) DNM1CES2LMNAALDH1A1HSD17B10
SCHEMBL15689292 0.79 DNM1 (0.47) DNM1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100418420-C Fungicide, composition thereof, use and fungicidal method thereof AJINOMOTO KK (JP) 2008-09-17 CN disclosed
EP-1285579-B1 Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate AJINOMOTO KK (JP) 2005-11-02 EP disclosed
US-20030162838-A1 Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism AJINOMOTO CO., INC. (JP) 2003-08-28 US disclosed
CN-1401240-A Fungicide, composition thereof, use and fungicidal method thereof AJINOMOTO KK (JP) 2003-03-12 CN disclosed
EP-1285579-A1 Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate Ajinomoto Co., Inc. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162838-A1 Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism ARG1, ALKBH1, GANC DNM1 1980/4885CES2 1147/4885CA2 1998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.